Abstract:A new validated method for the quantitation of the abnormal phospholipid phosphatidylethanol (PEth)--a biomarker for ethanol uptake--has been developed by LC-ESI-MS/MS following miniaturised organic solvent extraction and reversed phase chromatography with phosphatidylbutanol (PBut) as internal standard. PEth homologues with two fatty acid substituents-PEth 18:1/18:1, PEth 16:0/16:0-were determined in post-mortem blood collected from heavy drinkers at autopsy and also in whole blood samples from a volunteer af… Show more
“…Three blood spot volumes (20,35, 50 µL) were tested at low (0.32), intermediate (0.48) and high (0.67) hematocrit levels and at 2 concentrations; low and high. Six spots per concentration and per hematocrit level were prepared and centrally located 3 mm punches (1/DBS) were analysed.…”
Section: Methods Validationmentioning
confidence: 99%
“…Because the nonpolar part of PEths tends to interact very strongly with the nonpolar hydrocarbon phase of a reversed phase column, the use of a more polar phase (i.e. C8 [14,18,20], C4 [7,15] or phenyl [16]) instead of a C18 phase allows to decrease the retention of PEths [14]. The use of less polar solvents, such as tetrahydrofuran (index polarity = 4.0), isopropanol (index polarity = 3.9) or methanol (index polarity = 5.1) instead of acetonitrile (index polarity = 5.8) also improved the elution of PEths using a reversed phase column.…”
To refer to or to cite this work, please use the citation to the published version:Kummer N., Ingels A-S., Wille S. M.R., Hanak C. , Verbanck P. , Lambert W., Samyn N., Stove C.
“…Three blood spot volumes (20,35, 50 µL) were tested at low (0.32), intermediate (0.48) and high (0.67) hematocrit levels and at 2 concentrations; low and high. Six spots per concentration and per hematocrit level were prepared and centrally located 3 mm punches (1/DBS) were analysed.…”
Section: Methods Validationmentioning
confidence: 99%
“…Because the nonpolar part of PEths tends to interact very strongly with the nonpolar hydrocarbon phase of a reversed phase column, the use of a more polar phase (i.e. C8 [14,18,20], C4 [7,15] or phenyl [16]) instead of a C18 phase allows to decrease the retention of PEths [14]. The use of less polar solvents, such as tetrahydrofuran (index polarity = 4.0), isopropanol (index polarity = 3.9) or methanol (index polarity = 5.1) instead of acetonitrile (index polarity = 5.8) also improved the elution of PEths using a reversed phase column.…”
To refer to or to cite this work, please use the citation to the published version:Kummer N., Ingels A-S., Wille S. M.R., Hanak C. , Verbanck P. , Lambert W., Samyn N., Stove C.
“…A direct marker, which has also a potential in the field of abstinence monitoring, is phosphatidylethanol (PEth), as it is formed directly after alcohol intake [13,14].…”
“…Nevertheless, the advantages of mass spectrometry are-when compared to ELSD and UV-a higher specificity and sensitivity, short running times, and the possibility to detect single homologues instead of the sum of all homologues. LC-MS/MS and LC-TOF/MS methods have been developed with much lower limits of detection and running times of only 15 minutes (Gnann et al, 2009;Helander and Zheng, 2009;Tolonen et al, 2005). However, although sensitive and specific analyzing methods are known and homologues of PEth have been identified, the amount of data about the homologues of PEth relative to the background of drinking behaviors is still limited.…”
In addition to the approach to quantitate the PEth homologue 16:0/18:1, this is a new and alternative proceeding for the differentiation between alcoholics and social drinkers using this alcohol consumption marker.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.